LAVAL, Que. - Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.
The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.
The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.
Let's block ads! (Why?)
Bagikan Berita Ini
Related Posts :
Major Canadian canola exporter to China says finding new markets not easy
Andy Blatchford, The Canadian Press
Published Tuesday, April 2, 2019 2:17PM EDT
Last Updated Tuesd… Read More...
Chinese woman carrying malware allegedly got into Trump's Mar-a-Lago resort
Terry Spencer, The Associated Press
Published Wednesday, April 3, 2019 1:46AM EDT
FORT LAUDERDALE… Read More...
Malaysia to sell yacht at centre of 1MDB scandal for US$126M
KUALA LUMPUR, Malaysia -- Malaysia's government said Wednesday that a luxury yacht allegedly bought… Read More...
Asian shares edge higher ahead of U.S.-China trade talks
Annabelle Liang, The Associated Press
Published Wednesday, April 3, 2019 12:07AM EDT
SINGAPORE --… Read More...
Malaysian ex-PM Najib attends 1st day of graft trial
KUALA LUMPUR, Malaysia -- Former Malaysian Prime Minister Najib Razak appeared in court Wednesday f… Read More...
0 Response to "Valeant to sell Obagi skin-care business for US$190M"
Post a Comment